MAPK3 and head and neck squamous cell carcinoma: To evaluate the potential relevance of the above findings in aggressive HNSCC, we analyzed the protein expressions of osteopontin, Aurora-A, and phosphorylated ERK1/2 in 50 samples from patients with aggressive HNSCC by immunohistochemical staining.